On February 14, 2023, Oblato, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,340 KRW | -5.56% | -11.89% | +113.00% |
1st Jan change | Capi. | |
---|---|---|
+113.00% | 538M | |
+20.94% | 72.78B | |
-1.26% | 24.24B | |
+5.13% | 8.59B | |
+8.25% | 8.38B | |
-19.42% | 8.09B | |
+5.56% | 4.81B | |
+16.83% | 4.32B | |
-1.83% | 4.05B | |
+26.97% | 3.79B |
- Stock Market
- Equities
- A115450 Stock
- News HLB Therapeutics Co.,Ltd.
- Oblato, Inc. announced that it has received KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.